The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell Transplantation

NCT02976558 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2019-12-18

No results posted yet for this study

Summary

The allogenic stem cell transplantation (aSCT), the only curative approach for many hematological diseases, often leads to severe diseases or chronic conditions, leaving patients with physical disabilities and severe depression and impacting their quality of life in many cases. These consequences are still not adequately addressed by conventional therapies. In this study, the investigators examine the influence of the three complementary medicine methods (CAM) namely acupuncture according to Traditional Chinese Medicine (TCM), music therapy according to the TaKeTiNa method and the psychological disease processing by theatrical clown performance on the quality of life and the therapy process of patients before and after aSCT.

Conditions

  • Hematological Neoplasm
  • Graft-Versus-Host Disease
  • Depression
  • Stem Cell Transplant Complications
  • Quality of Life
  • Leukemia

Interventions

BEHAVIORAL

Clown theatrical Performance

PROCEDURE

Acupuncture

Acupuncture according to Traditional Chinese Medicine

BEHAVIORAL

Music Therapy TaKeTiNa

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-12-16
Completion
2019-12-16

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02976558 on ClinicalTrials.gov